| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |